Cholesterol medication and weight gain
Pro Research Analysisby 
Searched over 200M research papers
Statins and Weight Gain: Cholesterol Medication Side Effects
Several studies and case reports have observed a link between statin use (a common cholesterol-lowering medication) and weight gain. One case highlighted a clear temporal relationship where a patient experienced weight gain and increased appetite after starting statins, which resolved after switching to a different cholesterol-lowering agent. This suggests that statins may impair satiety, possibly through effects on hormones like leptin, leading to increased food intake and weight gain. The evidence also points out that some patients may adopt less healthy diets while on statins, believing they are protected from heart disease, which can further contribute to weight gain. However, even those maintaining healthy lifestyles may still experience weight gain due to the medication itself, not just behavioral changes .
LDL Cholesterol Lowering and Body Weight: Broader Implications
Large-scale genetic studies have shown that lowering LDL cholesterol (the main target of statin therapy) is associated with a modest increase in body mass index (BMI) and a higher risk of developing type 2 diabetes. About one-third of the increased diabetes risk from lowering LDL cholesterol appears to be mediated by weight gain, suggesting a biological link between cholesterol metabolism and body weight regulation .
Weight Gain and Lipid Changes with Other Medications
Other medications that affect cholesterol or are used in related conditions can also influence weight. For example, certain antipsychotics like risperidone are associated with dose-dependent weight gain and increases in cholesterol levels, though the magnitude is generally small . Some HIV medications and cancer therapies, such as lorlatinib, have also been shown to cause both weight gain and increases in cholesterol and triglyceride levels in a significant proportion of patients 78.
Weight-Loss Medications and Cholesterol
On the other hand, FDA-approved weight-loss medications generally lead to modest improvements in weight and some cardiometabolic risk factors, but their effects on cholesterol are usually small and vary by drug. No weight-loss medication has been shown to improve all aspects of the cholesterol profile significantly .
Individual Variation and Clinical Considerations
There is considerable variation in how individuals respond to cholesterol medications in terms of weight gain. Some people may experience significant weight gain, while others do not. The tendency for weight gain is often related to how the drug interacts with appetite-regulating pathways in the body. When possible, alternative therapies should be considered for patients who are at risk of obesity or are particularly concerned about weight gain .
Conclusion
Cholesterol-lowering medications, especially statins, can be associated with weight gain in some individuals, potentially through effects on appetite and satiety. This weight gain may also contribute to an increased risk of type 2 diabetes. Other medications used in related conditions can have similar effects. Patients and clinicians should be aware of these potential side effects and consider them when choosing the most appropriate therapy, especially for those already at risk for obesity or metabolic complications 1467+1 MORE.
Sources and full results
Most relevant research papers on this topic
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men
Mirtazapine treatment leads to unfavorable changes in lipid metabolism in healthy men, despite weight loss and standardized diets, supporting the hypothesis that it has direct pharmacological effects on lipid metabolism.
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.
Daily risperidone dose has a small but significant effect on weight gain and blood cholesterol levels, highlighting the importance of maintaining minimum effective dosages.
Obesity Partially Mediates the Diabetogenic Effect of Lowering LDL Cholesterol.
Lowering LDL cholesterol partially increases type 2 diabetes risk through increased BMI, highlighting the need for strategies to reduce diabetes risk among individuals taking LDL cholesterol-lowering medications.
Effects of Weight Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-Analysis
Weight-loss medications have only modest positive effects on cardiometabolic risk profiles in obese adults, with no drug improving all cardiometabolic risk factors.
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to coformulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
Switching to E/C/F/TAF in virally suppressed HIV-positive patients led to moderate weight gain and significant increases in lipid levels.
DOI